Results 31 to 40 of about 368,340 (301)

Serum microRNA-122 predicts survival in patients with liver cirrhosis

, 2012
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Stefan Zeuzem, Albrecht Piiper (22854), Oliver Waidmann, Kronenberger, Bernd, Friederike Brunner, Verena Köberle (130993), Bernd Kronenberger (131004), Bernd Kronenberger, Verena Köberle, Waidmann, Oliver, Albrecht Piiper, Oliver Waidmann (130988), Piiper, Albrecht, Friederike Brunner (130998), Köberle, Verena, Brunner, Friederike, Zeuzem, Stefan, Stefan Zeuzem (22856)   +17 more
core   +1 more source

Renal Dysfunction in End-Stage Liver Disease and Post–Liver Transplant

, 2014
Renal dysfunction is a frequent complication in patients with end-stage liver disease awaiting orthotopic liver transplantation and in the post–liver transplant period.
Martin, Paul, Sampaio, Marcelo S, Bunnapradist, Suphamai   +2 more
core   +1 more source

Clinical presentation of autoimmune hepatitis in Pakistani children

The Pan African Medical Journal, 2018
INTRODUCTION: Autoimmune hepatitis (AIH) is one of the most common disorder resulting in end stage liver disease (ESLD) among children. Scarce data is available in this regard from Pakistan.
Ghous Bux Somroo, Ayesha Aslam Rai, Nasir Hassan Luck, Zaigham Abbas   +3 more
doaj   +1 more source

Sarcopenia in Children With End‐Stage Liver Disease

Journal of Pediatric Gastroenterology and Nutrition, 2018
ABSTRACTBackground:Sarcopenia, reflected by decreased psoas muscle surface area (PMSA), has been identified as a novel and independent predictor of wait‐list mortality and outcomes in adult liver transplantation (LT). We hypothesized that children with end‐stage liver disease (ESLD) would have smaller PMSA than healthy controls.Methods:Computer ...
Eberhard, Lurz, Hiten, Patel, Richard G, Frimpong, Amanda, Ricciuto, Mohit, Kehar, Paul W, Wales, Alexander J, Towbin, Govind B, Chavhan, Binita M, Kamath, Vicky L, Ng   +9 more
openaire   +3 more sources

Body composition and components of energy expenditure in children with end-stage liver disease

, 2003
Background: Better understanding of body composition and energy metabolism in pediatric liver disease may provide a scientific basis for improved medical therapy aimed at achieving optimal nutrition, slowing progression to end-stage liver disease (ESLD),
Cleghorn, Geoffrey J., Greer, Ristan, Shepherd, Ross W., Shepherd, R. W., Lewindon, Peter, Lewindon, P., Greer, R., Lehnert, Megan, Lehnert, M.   +8 more
core   +1 more source

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review [PDF]

, 2011
Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried.
C Clar, Henderson, R., Gurung, T., N Waugh, N Sattar, N Ghouri, Clar, C., Sattar, Naveed, Sattar, N., Fraser, A., T Gurung, Gurung, T. (Tara), D Shyangdan, A Fraser, Shyangdan, D., D Preiss, Waugh, Norman, Shyangdan, D. (Deepson), R Henderson, Ghouri, N., Preiss, D., Waugh, N.   +21 more
core   +1 more source

In Vitro Evaluation of Pro- and Anticoagulant Drugs in Children with End-Stage Liver Disease Undergoing Liver Transplantation [PDF]

, 2020
Background âPro- A nd anticoagulant drugs are commonly used in pediatric liver transplantation to prevent and treat thrombotic and bleeding complications.
Werner, Maureen J M, de Kleine, Ruben H J; id_orcid, Scheenstra, René, Bontemps, Sander T H, Hulscher, Jan B F, de Meijer, Vincent E, Porte, Robert J, Reyntjens, Koen M E M, Adelmeijer, Jelle, Lisman, Ton; id_orcid, Lisman, Ton, de Meijer, Vincent E; id_orcid, de Kleine, Ruben H J   +12 more
core   +1 more source

Sarcopenia in end-stage liver disease and after liver transplantation

Acta Gastro Enterologica Belgica, 2023
Sarcopenia occurs in 30-70% of patients with end-stage liver disease and is associated with inferior pre- and post-liver transplant outcomes such as prolonged intubation times, long intensive care and hospitalization times, heightened risk of post-transplant infection, reduced health-related quality of life, and increased rates of mortality.
Leunis, S., Vandecruys, M., Craenenbroeck, A.H. Van, Cornelissen, V., Bogaerts, S., De Smet, S., Monbaliu, D.   +6 more
openaire   +2 more sources

Role of Rifaximin in Prevention of Recurrent Hepatic Encephalopathy in Chronic Liver Disease

Journal of Bahria University Medical and Dental College, 2020
Objectives: To determine the efficacy (in terms of recurrence) of rifaximin in Hepatic Encephalopathy (HE) in chronic liver disease. Study Design and Setting: A descriptive study carried out from 4th September 2018 to 3rd March 2019 at the department of
Sahar Farzand, Abdul Latif Khattak, Rafi ud Din, Karamat Hussain Shah Bukhari, Muhammad Shahbaz Amin, Shahzeb Ahmed Satti   +5 more
doaj   +1 more source

Albumin for End-Stage Liver Disease

The Korean Journal of Internal Medicine, 2012
Albumin has been widely used in patients with cirrhosis in an attempt to improve circulatory and renal functions. The benefits of albumin infusions in preventing the deterioration in renal function associated with large-volume paracentesis, spontaneous bacterial peritonitis, and established hepatorenal syndrome in conjunction with a vasoconstrictor are
openaire   +2 more sources